An Australian trial which used a marijuana extract to treat 40 children with severe epilepsy found the drug has a manageable side effect profile, but only shows extensive symptom relief for a select number of patients.
Following treatment with cannabidiol, a non-psychoactive compound found in marijuana, about one in
five were described as much or very much improved from their baseline, while around half reported
none, or a very slight improvement.
“This was a statewide study in New South Wales and it involves the sickest children with epilepsy
in the state.
– Read the entire article at Punch News.
